Portman Square Capital LLP Alnylam Pharmaceuticals, Inc. Put Options Transaction History

Portman Square Capital LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 Apr 15, 2024	BUY	$146.51 - $198.2 $776,503 - $1.05 Million	5,300 Added 10.39%	56,300 $8.41 Million
Q3 2023 Oct 30, 2023	BUY	$170.77 - $211.65 $5.12 Million - $6.35 Million	30,000 Added 142.86%	51,000 $9.03 Million
Q2 2023 Jul 26, 2023	SELL	$185.01 - $212.05 $6.11 Million - $7 Million	-33,000 Reduced 61.11%	21,000 $3.99 Million
Q1 2023 May 04, 2023	BUY	$182.66 - $235.53 $4.38 Million - $5.65 Million	24,000 Added 80.0%	54,000 $10.8 Million
Q4 2022 Feb 23, 2023	BUY	$185.53 - $241.31 $5.57 Million - $7.24 Million	30,000 New	30,000 $7.13 Billion

614

108M

2.33M

2.17M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Portman Square Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Portman Square Capital LLP with notifications on news.